Clinical presentations that can sometimes be misleading in women who are carriers of FHL1-related myopathy

French clinicians have compiled clinical and genetic data from five female patients who were ultimately diagnosed as ‘carriers’ of myopathy linked to the FHL1 gene (located on the X chromosome):

  • the average age of onset of the first symptoms was 13 years,
  • all patients had motor impairment, which was asymmetrical at the outset,
  • in four of them, loss of the ability to walk was observed after an average of six years’ progression,
  • the rapid rate of motor deterioration, combined with the pseudo-inflammatory appearance on imaging, had led to the mistaken suggestion of a myositis-like process,
  • muscle biopsy ultimately revealed the presence of reducing bodies, raising suspicion of FHL1 gene involvement, which was subsequently confirmed by molecular biology.

The authors advocate investigating a hereditary cause in cases of atypical inflammatory myopathy.